Finch Therapeutics Group (FNCH) Short Interest Ratio & Short Volume $12.44 +0.02 (+0.12%) As of 08/7/2025 03:55 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsInsider TradesSEC FilingsShort InterestTrendsBuy This Stock Finch Therapeutics Group Short Interest DataFinch Therapeutics Group (FNCH) has a short interest of 100 shares. This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 2,035 shares to cover all short positions.Current Short Interest100 sharesPrevious Short Interest100 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$1.28 thousandShort Interest Ratio0.1 Days to CoverLast Record DateJuly 15, 2025Outstanding Shares1,606,000 sharesPercentage of Shares Shorted0.01%Today's Trading Volume2,622 sharesAverage Trading Volume2,035 sharesToday's Volume Vs. Average129% Short Selling Finch Therapeutics Group? Sign up to receive the latest short interest report for Finch Therapeutics Group and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartFNCH Short Interest Over TimeFNCH Days to Cover Over TimeFNCH Percentage of Float Shorted Over Time Finch Therapeutics Group Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/2025100 shares $1.28 thousand No ChangeN/A0.1 $12.75 6/30/2025100 shares $1.32 thousand -88.9%0.0%0 $13.20 6/15/2025900 shares $12.38 thousand No Change0.1%0.6 $13.75 5/31/2025900 shares $12.15 thousand +12.5%0.1%0.3 $13.50 5/15/2025800 shares $10.57 thousand -11.1%N/A0.2 $13.21 4/30/2025900 shares $11.25 thousand -18.2%N/A0.1 $12.50 4/15/20251,100 shares $14.63 thousand -31.3%N/A0.3 $13.30 3/14/20251,600 shares $21.84 thousand No ChangeN/A0.3 $13.65 2/28/20251,600 shares $25.26 thousand -36.0%N/A0.4 $15.79 2/14/20252,500 shares $37.50 thousand +66.7%N/A0.3 $15.00 Get the Latest News and Ratings for FNCH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Finch Therapeutics Group and its competitors with MarketBeat's FREE daily newsletter. 1/31/20251,500 shares $16.88 thousand No ChangeN/A0.8 $11.25 1/15/20251,500 shares $16.37 thousand -6.3%N/A0.9 $10.91 5/15/202419,200 shares $40.32 thousand -27.3%2.8%0.3 $2.10 4/30/202426,400 shares $61.78 thousand +149.1%4.9%0.5 $2.34 4/15/202410,600 shares $23.80 thousand +15.2%2.0%0.2 $2.25 3/31/20249,200 shares $23.92 thousand -20.7%1.7%0.5 $2.60 3/15/202411,600 shares $29.64 thousand +383.3%2.2%0.6 $2.56 2/29/20242,400 shares $6.24 thousand -27.3%0.5%0.1 $2.60 2/15/20243,300 shares $8.25 thousand +65.0%0.6%0.1 $2.50 1/31/20242,000 shares $5.50 thousand +300.0%0.4%0.1 $2.75 1/15/2024500 shares $1.56 thousand -73.7%0.1%0 $3.11 12/31/20231,900 shares $6.86 thousand -65.5%0.4%0.1 $3.61 12/15/20235,500 shares $18.92 thousand -61.3%1.0%0.3 $3.44 11/30/202314,200 shares $61.06 thousand -27.9%2.5%1.7 $4.30 11/15/202319,700 shares $79.00 thousand -3.9%3.4%2.8 $4.01 10/31/202320,500 shares $79.54 thousand -11.6%3.6%2.8 $3.88 10/15/202323,200 shares $103.94 thousand -4.1%4.1%2.6 $4.48 9/30/202324,200 shares $125.36 thousand -15.1%4.3%2.5 $5.18 9/15/202328,500 shares $163.59 thousand +27.2%5.1%2.7 $5.74 8/31/202322,400 shares $144.70 thousand +4.7%4.0%0.6 $6.46 8/15/202321,400 shares $133.96 thousand +57.4%3.8%0.6 $6.26 7/31/202313,600 shares $104.18 thousand -20.0%0.1%0.4 $7.66 7/15/202317,000 shares $155.89 thousand -25.4%0.1%0.5 $9.17 6/30/202322,800 shares $194.48 thousand -20.8%4.0%0.6 $8.53 6/15/202328,800 shares $249.12 thousand -73.1%5.1%0.8 $8.65 5/31/2023106,900 shares $897.96 thousand +73.5%0.6%0.4 $8.40 5/15/202361,600 shares $22.27 thousand -73.3%0.4%0.2 $0.36 4/30/2023230,300 shares $92.86 thousand +83.1%1.4%0.8 $0.40 4/15/2023125,800 shares $49.36 thousand +47.0%0.7%0.4 $0.39 3/31/202385,600 shares $33.64 thousand -9.9%0.5%0.5 $0.39HIDDEN IN THE BOOK OF GENESIS… (Ad)“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth. Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation.Watch Jim Rickards reveal the Old Testament Wealth Code 3/15/202395,000 shares $35.15 thousand -51.7%0.6%0.5 $0.37 2/28/2023196,500 shares $81.35 thousand +10.2%1.2%1.2 $0.41 2/15/2023178,400 shares $75.12 thousand +49.8%1.1%1.1 $0.42 1/31/2023119,100 shares $59.55 thousand -4.4%0.7%0.9 $0.50 1/15/2023124,600 shares $69.78 thousand +22.4%0.8%1.2 $0.56 12/30/2022101,800 shares $48.86 thousand +27.4%0.6%1.4 $0.48 12/15/202279,900 shares $64.71 thousand +6.4%0.5%1.3 $0.81 11/30/202275,100 shares $73.61 thousand -17.7%0.5%1.8 $0.98 11/15/202291,300 shares $98.44 thousand -17.9%0.6%2.1 $1.08 10/31/2022111,200 shares $144.56 thousand -6.1%0.7%2.5 $1.30 10/15/2022118,400 shares $188.26 thousand -21.0%0.7%2.6 $1.59 9/30/2022149,900 shares $250.33 thousand +19.6%1.0%3.2 $1.67 9/15/2022125,300 shares $334.55 thousand -12.7%0.8%2 $2.67 8/31/2022143,600 shares $310.18 thousand -37.9%1.0%2 $2.16 8/15/2022231,400 shares $647.92 thousand -19.6%1.5%2.8 $2.80 7/31/2022287,700 shares $561.02 thousand +0.6%1.9%2.4 $1.95 7/15/2022285,900 shares $651.85 thousand -24.5%1.9%0.3 $2.28 6/30/2022378,600 shares $1.08 million -41.3%2.5%0.4 $2.84 6/15/2022644,700 shares $1.75 million -14.1%4.3%0.7 $2.71 5/31/2022750,800 shares $1.78 million -0.6%5.0%0.8 $2.37 5/15/2022755,200 shares $1.68 million +296.0%5.0%0.8 $2.23 4/30/2022190,700 shares $482.47 thousand +2.3%1.3%0.2 $2.53 4/15/2022186,500 shares $760.92 thousand -13.1%1.2%5.3 $4.08 3/31/2022214,500 shares $1.08 million -9.0%1.4%6.3 $5.03 3/15/2022235,700 shares $1.22 million -6.5%1.6%5.7 $5.17 2/28/2022252,200 shares $2.11 million -0.4%1.7%3.5 $8.37 2/15/2022253,100 shares $2.21 million -0.5%1.7%3 $8.75 1/31/2022254,300 shares $2.16 million +9.9%1.5%2.5 $8.48 1/15/2022231,400 shares $2.11 million -8.9%1.4%2.1 $9.10 12/31/2021253,900 shares $2.53 million +58.1%1.5%2.3 $9.97 12/15/2021160,600 shares $1.52 million -30.5%1.0%1.5 $9.47 11/30/2021231,100 shares $3.84 million +22.5%1.4%2.9 $16.62 11/15/2021188,700 shares $2.74 million +0.4%1.1%3.1 $14.54 10/29/2021187,900 shares $2.52 million -19.1%1.1%4 $13.40 10/15/2021232,200 shares $2.77 million -2.6%1.4%6.8 $11.95 9/30/2021238,300 shares $3.10 million -2.4%1.4%5 $13.00 9/15/2021244,100 shares $3.38 million -16.6%1.5%3.7 $13.83 8/31/2021292,800 shares $4.14 million -31.0%1.8%4 $14.15 8/13/2021424,600 shares $5.58 million No Change2.5%5.7 $13.15 FNCH Short Interest - Frequently Asked Questions What is Finch Therapeutics Group's current short interest? Short interest is the volume of Finch Therapeutics Group shares that have been sold short but have not yet been closed out or covered. As of July 15th, investors have sold 100 shares of FNCH short. Learn More on Finch Therapeutics Group's current short interest. How does Finch Therapeutics Group's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Finch Therapeutics Group: IGM Biosciences, Inc. (2.42%), Cabaletta Bio, Inc. (12.89%), Celularity, Inc. (11.22%), PMV Pharmaceuticals, Inc. (1.76%), Immix Biopharma, Inc. (1.38%), Sutro Biopharma, Inc. (4.33%), Assertio Holdings, Inc. (5.87%), Pyxis Oncology, Inc. (10.86%), Genenta Science S.p.A. Unsponsored ADR (0.04%), Atara Biotherapeutics, Inc. (7.02%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks. What does it mean to sell short Finch Therapeutics Group stock? Short selling FNCH is an investing strategy that aims to generate trading profit from Finch Therapeutics Group as its price is falling. FNCH shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Finch Therapeutics Group? A short squeeze for Finch Therapeutics Group occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of FNCH, which in turn drives the price of the stock up even further. How often is Finch Therapeutics Group's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FNCH, twice per month. The most recent reporting period available is July, 15 2025. More Short Interest Resources from MarketBeat Related Companies IGMS Short Squeeze CABA Short Squeeze CELU Short Squeeze PMVP Short Squeeze IMMX Short Squeeze STRO Short Squeeze ASRT Short Squeeze PYXS Short Squeeze GNTA Short Squeeze ATRA Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:FNCH) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe Coin That Could Define Trump’s Crypto PresidencyWhen Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top ad...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Finch Therapeutics Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Finch Therapeutics Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FNCH Stock Alerts